primary antibodies and peptides 10239 Flanders Court, San Diego, CA 92121, USA. sales@abgent.com
Tel: 858.622.0099, 888-735-7227 (US toll free) Fax: 858-622-0609 (US toll free)

MAGEB3 Antibody (N-term)
Purified Rabbit Polyclonal Antibody (Pab)

Catalog # Source: Lot # Size:
AP6173a Rabbit SH030117O; SH030117P 0.1 mg
Concentration: Accession: Clone Name: Isotype:
0.25 mg/ml NP_002356 RB2105/2106 Rabbit Ig
Applications: Reactivity: MW (kDa):
IHC, E H 39179 Da
Target/Specificity:
This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human MAGEB3.
Other Names:
Application Data:
MAGEB3 Antibody (N-term)

Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Background:
MAGEB3 is a MAGE-B subfamily member of the MAGE gene family. MAGE family member proteins direct the expression of tumor antigens recognized on a human melanoma by autologous cytolytic T lymphocytes. There are two known clusters of MAGE genes on chromosome X. The members of the MAGE-A subfamily are located in the Xq28 region, while the members of the MAGE-B subfamily are clustered in the Xp21 region.
Background References:
  1. Lurquin, C., et al., Genomics 46(3):397-408 (1997).
Product Citations:
Application Notes:
The suggested dilution will be:
ELISA1:1,000
Immunohistochemistry1:50~100
Format:
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Storage:
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions:
This product is for research use only. Not for use in diagnostic or therapeutic procedures.